278 related articles for article (PubMed ID: 26182894)
1. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.
Rentzsch J; Stadtmann A; Montag C; Kunte H; Plöckl D; Hellweg R; Gallinat J; Kronenberg G; Jockers-Scherübl MC
Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):409-21. PubMed ID: 26182894
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.
Rentzsch J; Penzhorn A; Kernbichler K; Plöckl D; Gómez-Carrillo de Castro A; Gallinat J; Jockers-Scherübl MC
Exp Neurol; 2007 May; 205(1):241-9. PubMed ID: 17368620
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of cannabis use on the auditory mismatch negativity.
Greenwood LM; Broyd SJ; Croft R; Todd J; Michie PT; Johnstone S; Murray R; Solowij N
Biol Psychiatry; 2014 Mar; 75(6):449-58. PubMed ID: 23830666
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
Fisher DJ; Smith DM; Labelle A; Knott VJ
Biol Psychol; 2014 Jul; 100():43-9. PubMed ID: 24865523
[TBL] [Abstract][Full Text] [Related]
6. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia.
Ozgürdal S; Gudlowski Y; Witthaus H; Kawohl W; Uhl I; Hauser M; Gorynia I; Gallinat J; Heinze M; Heinz A; Juckel G
Schizophr Res; 2008 Oct; 105(1-3):272-8. PubMed ID: 18625546
[TBL] [Abstract][Full Text] [Related]
7. Opposing Effects of Cannabis Use on Late Auditory Repetition Suppression in Schizophrenia Patients and Healthy Control Subjects.
Rentzsch J; Kronenberg G; Stadtmann A; Neuhaus A; Montag C; Hellweg R; Jockers-Scherübl MC
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Apr; 2(3):263-271. PubMed ID: 29528297
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evidence of early attentional bias to drug-related pictures in chronic cannabis users.
Asmaro D; Carolan PL; Liotti M
Addict Behav; 2014 Jan; 39(1):114-21. PubMed ID: 24126204
[TBL] [Abstract][Full Text] [Related]
9. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
Rabin RA; Barr MS; Goodman MS; Herman Y; Zakzanis KK; Kish SJ; Kiang M; Remington G; George TP
Neuropsychopharmacology; 2017 Oct; 42(11):2259-2271. PubMed ID: 28443616
[TBL] [Abstract][Full Text] [Related]
10. Event-related potentials in patients with adult attention-deficit/hyperactivity disorder versus schizophrenia.
Itagaki S; Yabe H; Mori Y; Ishikawa H; Takanashi Y; Niwa S
Psychiatry Res; 2011 Sep; 189(2):288-91. PubMed ID: 21458861
[TBL] [Abstract][Full Text] [Related]
11. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
[TBL] [Abstract][Full Text] [Related]
12. Auditory P300 in individuals clinically at risk for psychosis.
Frommann I; Brinkmeyer J; Ruhrmann S; Hack E; Brockhaus-Dumke A; Bechdolf A; Wölwer W; Klosterkötter J; Maier W; Wagner M
Int J Psychophysiol; 2008 Dec; 70(3):192-205. PubMed ID: 18700155
[TBL] [Abstract][Full Text] [Related]
13. Chronic effects of cannabis on sensory gating.
Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N
Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289
[TBL] [Abstract][Full Text] [Related]
14. P300 event-related potential in abstinent methamphetamine-dependent patients.
Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
[TBL] [Abstract][Full Text] [Related]
15. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
Rabin RA; Kozak K; Zakzanis KK; Remington G; George TP
Schizophr Res; 2018 Apr; 194():55-61. PubMed ID: 28285022
[TBL] [Abstract][Full Text] [Related]
16. Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia.
Xiong P; Zeng Y; Zhu Z; Tan D; Xu F; Lu J; Wan J; Ma M
Schizophr Res; 2010 Jun; 119(1-3):34-9. PubMed ID: 20303241
[TBL] [Abstract][Full Text] [Related]
17. Affect processing and positive syndrome schizotypy in cannabis users.
Skosnik PD; Park S; Dobbs L; Gardner WL
Psychiatry Res; 2008 Jan; 157(1-3):279-82. PubMed ID: 17897720
[TBL] [Abstract][Full Text] [Related]
18. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
[TBL] [Abstract][Full Text] [Related]
19. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
